We recommended that clinicians consistently provide transition follow-up to inpatients with newly prescribed anticoagulant medications in accordance with local policy and that facility managers monitor compliance.
Questioned Costs
$0
Funds for Better Use
$0
Recommendation Status
Closed
Source UUID
16-00573-309-6
Report
Recommendation Number
6
Significant Recommendation
Yes